{"gene":"KCNC2","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":2000,"finding":"Kv3.2 knockout mice showed impaired high-frequency firing specifically in fast-spiking (FS) GABAergic interneurons of deep cortical layers (5-6) where Kv3.2 is normally prominently expressed, but not in superficial layer FS neurons where Kv3.2 is weakly expressed. This establishes Kv3.2 as necessary for high-frequency firing in these interneurons.","method":"Whole-cell electrophysiological recording in Kv3.2 knockout mice; immunocytochemical identification of FS interneurons","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with layer-specific electrophysiological phenotype, multiple orthogonal methods, replicated across conditions","pmids":["11124984"],"is_preprint":false},{"year":2000,"finding":"Kv3.2 knockout mice showed altered cortical EEG patterns and increased susceptibility to epileptic seizures, consistent with suppression of inhibitory interneuron activity rather than hyperexcitability of interneurons, demonstrating Kv3.2 is required for normal cortical inhibitory function.","method":"EEG recording and seizure susceptibility testing in Kv3.2 knockout mice","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined EEG and behavioral phenotype, multiple readouts in same study","pmids":["11124984"],"is_preprint":false},{"year":2000,"finding":"H2 histamine receptor activation negatively modulates outward currents through Kv3.2-containing potassium channels via PKA phosphorylation in hippocampal inhibitory interneurons, lowering maximal firing frequency and suppressing high-frequency population oscillations. All these effects were absent in Kv3.2 knockout mice.","method":"Electrophysiology in interneurons; PKA pharmacology; Kv3.2 knockout mouse comparison; population oscillation recordings","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout rescue experiment confirming specificity, multiple orthogonal methods (pharmacology, electrophysiology, knockout validation)","pmids":["10903572"],"is_preprint":false},{"year":1999,"finding":"Kv3.1 and Kv3.2 proteins form heteromeric channels in parvalbumin-containing pallidal neurons, as demonstrated by co-immunoprecipitation of both subunits from pallidal membrane extracts. These channels underlie the high-voltage-activating, fast-deactivating delayed rectifier K+ current in these neurons.","method":"Co-immunoprecipitation from pallidal membrane extracts; electrophysiological recording of freshly dissociated pallidal neurons; heterologous expression comparison","journal":"Journal of neurophysiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP combined with electrophysiological characterization of native vs heterologous channels, multiple orthogonal methods","pmids":["10482766"],"is_preprint":false},{"year":2002,"finding":"Kv3.2 and Kv3.1b are co-expressed within the same protein complexes in the hippocampus, as shown by immunoprecipitation. Kv3.2 protein is clustered on somata and proximal dendrites of parvalbumin-positive (100%), nitric oxide synthase-positive (86%), and somatostatin-positive (~50%) hippocampal interneurons, but absent from calbindin- and calretinin-containing interneurons.","method":"Immunoprecipitation from hippocampal tissue; immunohistochemistry; double immunofluorescence","journal":"Hippocampus","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and immunolocalization from single lab with multiple cell-type markers","pmids":["12000114"],"is_preprint":false},{"year":2004,"finding":"Kv3.2 is selectively localized to basket cell axons within the cerebellar pinceau (the structure formed by basket cell axons converging on Purkinje cell initial axonal segments), suggesting a role in regulating the microenvironment of the Purkinje cell axon initial segment.","method":"Immunohistochemistry, electron microscopy, and electron tomography","journal":"Brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ultrastructural localization by electron tomography, single lab, no direct functional manipulation","pmids":["15488478"],"is_preprint":false},{"year":2005,"finding":"ShK (Stichodactyla helianthus peptide) potently inhibits homomeric Kv3.2b channels (IC50 ~0.3–6 nM depending on assay). In mouse cortical GABAergic fast-spiking interneurons, ShK application increased action potential half-width, decreased after-hyperpolarization amplitude, and decreased maximal firing frequency, consistent with Kv3 channel blockade. However, despite Kv3.2 protein presence in human pancreatic beta cells, ShK had no effect on their Kv current, indicating homotetrameric Kv3.2 channels do not contribute significantly to beta cell delayed rectifier current.","method":"86Rb+ efflux assay; electrophysiology in Xenopus oocytes and planar patch-clamp; whole-cell patch-clamp in cortical interneurons","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple quantitative in vitro assays across expression systems, native cell validation, single lab","pmids":["15709110"],"is_preprint":false},{"year":2016,"finding":"A de novo KCNC2 variant (p.D167Y) identified in a patient with drug-resistant epilepsy demonstrated both a strong loss-of-function effect on current amplitude and a gain-of-function effect on channel activation, indicating a complex functional consequence of this variant.","method":"Electrophysiological studies of variant channel expressed in heterologous system","journal":"Neuropediatrics","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro electrophysiology of variant channel, single lab, single method","pmids":["32392612"],"is_preprint":false},{"year":2022,"finding":"Functional electrophysiological analysis of KCNC2 disease variants in Xenopus laevis oocytes demonstrated gain-of-function in 3 severely affected DEE cases (altered voltage dependence, kinetics) and loss-of-function in 1 milder GGE case, linking specific biophysical mechanisms to clinical severity.","method":"Electrophysiology in Xenopus laevis oocytes; exome sequencing","journal":"Neurology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro electrophysiology of multiple variants in expression system, multiple variants tested, single lab","pmids":["35314505"],"is_preprint":false},{"year":2022,"finding":"Computational structural modeling and electrophysiological analyses of two proximal KCNC2 variants (p.V469L and p.V471L) revealed heterogeneous mechanisms: p.V469L sterically blocks the channel pore (loss-of-function), while p.V471L stabilizes the open conformation (gain-of-function). Molecular dynamics simulations confirmed that p.V469L increases the energetic barrier for K+ permeation, while p.V471L stabilizes the open state. Both showed differential responses to 4-aminopyridine.","method":"Whole-exome sequencing; computational structural modeling; electrophysiology (patch-clamp); molecular dynamics simulations; 4-AP pharmacology","journal":"HGG advances","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods (structural modeling, electrophysiology, MD simulations, pharmacology) on two variants in single study","pmids":["36035247"],"is_preprint":false},{"year":2024,"finding":"The epilepsy-associated Kv3.2-p.Cys125Tyr variant causes gain-of-function via a hyperpolarizing shift in voltage dependence of activation, accelerated activation, and delayed deactivation. Cryo-EM structure of Kv3.1 combined with molecular dynamics simulations revealed that Tyr125 forms a π-π stacking interaction with Tyr156 in the α-6 helix of the T1 domain, stabilizing the open conformation. A computational parvalbumin-positive interneuron model demonstrated that this variant impairs neuronal excitability and dysregulates cortical inhibition.","method":"Electrophysiology of variant channel; cryo-EM structure leveraging; molecular dynamics simulations; multicompartment computational neuron modeling","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — structure-guided mechanism with MD simulation, electrophysiological validation, and computational network modeling; multiple orthogonal methods","pmids":["38194456"],"is_preprint":false},{"year":2022,"finding":"Two novel de novo KCNC2 variants (p.Pro470Ser and p.Phe388Leu) in DEE patients demonstrated decreased channel activation and deactivation kinetics in whole-cell patch-clamp recordings from HEK293 cells. p.Phe388Leu and p.Val471Leu variants also showed increased channel conductance and ~20 mV negative shift in voltage-dependent activation threshold. Computational model simulations showed all variants decreased interneuron firing frequency, producing net loss-of-function with disinhibition of neural networks.","method":"Whole-cell patch-clamp in HEK293 cells; computational GABAergic interneuron modeling","journal":"Seizure","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro patch-clamp combined with computational modeling, single lab, multiple variants tested","pmids":["36087422"],"is_preprint":false},{"year":2023,"finding":"Electrophysiological studies of KCNC2 variants of uncertain significance in Xenopus laevis oocytes showed changes in current amplitude and activation/deactivation kinetics depending on the variant. Valproic acid showed no direct effect on Kv3.2 channel behavior in oocytes, suggesting its therapeutic benefit in KCNC2 variant patients occurs through other mechanisms.","method":"Electrophysiology in Xenopus laevis oocytes; valproic acid pharmacology","journal":"Frontiers in neurology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro electrophysiology of multiple variants including negative result for VPA, single lab","pmids":["37360341"],"is_preprint":false},{"year":2025,"finding":"The Kv3.2-V473A variant (GOF) activates at more hyperpolarized potentials than wild-type Kv3.2 in HEK293 cells. Fluoxetine inhibits both Kv3.2 WT and Kv3.2-V473A variant channels with IC50 ~12 µM. Norfluoxetine (fluoxetine metabolite) inhibits Kv3.2 variant currents with 7-fold greater selectivity (IC50 ~0.4 µM for variant vs ~2.9 µM for WT), selectively suppressing dominant pathogenic channel activity.","method":"Whole-cell patch-clamp in HEK293 cells; pharmacological dose-response for fluoxetine and norfluoxetine","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro electrophysiology with quantitative IC50 measurements for pharmacological inhibition, single lab, single method","pmids":["39881864"],"is_preprint":false},{"year":2023,"finding":"Decreased phosphorylation of the Kv3.2 channel contributed to hyperactivation of the mediodorsal thalamic nucleus (MD) in a PTSD mouse model, and correction of this channelopathy via siRNA-targeting of protein phosphatase 6 catalytic subunit (using lipid nanoparticle-based RNA therapy) restored fear memory extinction.","method":"Functional screening; RNA therapy (lipid nanoparticle-based siRNA); fear extinction behavioral assay; machine learning analysis of neuronal encoding","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo siRNA rescue with behavioral readout and mechanistic link to phosphorylation state, single lab, multiple methods","pmids":["38102998"],"is_preprint":false},{"year":2008,"finding":"Kv3.2 mRNA and protein expression in developing rat visual cortex is regulated by neuronal activity: chronic activity deprivation from early postnatal stages prevented postnatal increase in Kv3.2 mRNA; TTX-mediated deprivation reduced Kv3.2 protein. MEK2 signaling appears required for Kv3.2 translation (inhibiting MAPK signaling decreased Kv3.2 protein levels). BDNF and NT4 did not significantly change Kv3.2 protein levels.","method":"Organotypic cultures; RT-PCR; Western blot; TTX/glutamate receptor blocker pharmacology; MAPK inhibition","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — multiple pharmacological manipulations in organotypic cultures with mRNA and protein readouts, single lab","pmids":["18775767"],"is_preprint":false},{"year":2016,"finding":"KCNC2 shRNA knockdown in cellular and mouse models induced endoplasmic reticulum (ER) stress and increased hepatic gluconeogenesis, while KCNC2 overproduction decreased ER stress, demonstrating a role in hepatic metabolic regulation.","method":"shRNA knockdown; overexpression in cellular and mouse models; ER stress markers; gluconeogenesis assays","journal":"Scientific reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single shRNA approach, non-neuronal context inconsistent with primary function described in most corpus papers","pmids":["27623749"],"is_preprint":false}],"current_model":"Kv3.2 (KCNC2) is a voltage-gated K+ channel subunit that activates at very depolarized potentials (positive to -10 mV) and deactivates rapidly; it forms homotetrameric and heteromeric channels (notably with Kv3.1) clustered on somata and proximal dendrites of parvalbumin-positive fast-spiking GABAergic interneurons, where it is required for sustained high-frequency firing, cortical inhibitory tone, and network oscillations. Its activity is regulated by PKA phosphorylation downstream of H2 histamine receptor signaling, and disease-associated de novo variants cause either gain-of-function (via stabilization of the open conformation, as structurally explained by π-π stacking or open-state stabilization) or loss-of-function (via pore block or kinetic slowing), both of which impair interneuron excitability and produce developmental and epileptic encephalopathy."},"narrative":{"mechanistic_narrative":"KCNC2 encodes Kv3.2, a high-voltage-activating, fast-deactivating voltage-gated K+ channel subunit that endows fast-spiking GABAergic interneurons with the capacity for sustained high-frequency firing and thereby sets cortical inhibitory tone [PMID:11124984]. The channel assembles as homotetramers and as heteromers with Kv3.1, forming the delayed-rectifier current of parvalbumin-positive interneurons in cortex, hippocampus, pallidum, and cerebellar basket cells, where Kv3.2 protein clusters on somata, proximal dendrites, and specialized axonal structures such as the cerebellar pinceau [PMID:10482766, PMID:12000114, PMID:15488478]. Loss of Kv3.2 selectively impairs deep-layer interneuron high-frequency firing and produces abnormal EEG activity and seizure susceptibility, establishing that interneuron repolarization by Kv3.2 is required for normal network inhibition [PMID:11124984]. Channel output is dynamically tuned by phosphorylation: H2 histamine-receptor signaling acting through PKA suppresses Kv3.2 current and lowers maximal firing frequency, and reduced channel phosphorylation drives pathological thalamic hyperactivation in a PTSD model [PMID:10903572, PMID:38102998]. De novo KCNC2 variants cause developmental and epileptic encephalopathy through two opposing biophysical routes — gain-of-function via hyperpolarizing shifts in activation, accelerated activation, and delayed deactivation (structurally explained by open-state-stabilizing interactions including π-π stacking in the T1 domain), and loss-of-function via pore block or kinetic slowing — both of which impair interneuron excitability and dysregulate cortical inhibition [PMID:35314505, PMID:36035247, PMID:38194456, PMID:36087422]. Variant-selective pharmacology, including norfluoxetine's preferential inhibition of gain-of-function channels, points toward mechanism-matched therapeutic strategies [PMID:39881864].","teleology":[{"year":2000,"claim":"Establishing whether Kv3.2 is functionally required in vivo, genetic deletion pinpointed it as necessary for high-frequency firing in deep-layer fast-spiking interneurons and for normal cortical inhibition, with its loss causing abnormal EEG and seizure susceptibility.","evidence":"Whole-cell electrophysiology, EEG, and seizure testing in Kv3.2 knockout mice with immunocytochemical interneuron identification","pmids":["11124984"],"confidence":"High","gaps":["Did not resolve subunit stoichiometry of native channels","Layer- and cell-type specificity of phenotype incompletely mapped beyond deep-layer FS neurons"]},{"year":1999,"claim":"Addressing how the native delayed-rectifier current is built, co-immunoprecipitation showed Kv3.2 forms heteromeric channels with Kv3.1 in parvalbumin-positive neurons, explaining the high-voltage-activating, fast-deactivating current.","evidence":"Reciprocal co-IP from pallidal membranes plus electrophysiology of native and heterologous channels","pmids":["10482766"],"confidence":"High","gaps":["Heteromer stoichiometry not determined","Functional contribution of homomers vs heteromers in vivo not separated"]},{"year":2000,"claim":"To define how channel output is regulated, H2 histamine receptor signaling was shown to suppress Kv3.2 current via PKA phosphorylation, lowering interneuron firing and high-frequency oscillations, with effects absent in knockouts.","evidence":"Interneuron electrophysiology, PKA pharmacology, population oscillation recordings, and knockout controls","pmids":["10903572"],"confidence":"High","gaps":["Phosphorylation sites on Kv3.2 not mapped","Direct vs indirect PKA action on the channel not distinguished"]},{"year":2002,"claim":"Refining cell-type localization, Kv3.2 was found clustered on somata and proximal dendrites of defined hippocampal interneuron subsets and co-complexed with Kv3.1b, sharpening which inhibitory cells depend on this channel.","evidence":"Immunoprecipitation and double immunofluorescence in hippocampal tissue","pmids":["12000114"],"confidence":"Medium","gaps":["Single-lab immunolocalization","Functional consequence of differential subcellular clustering not tested"]},{"year":2004,"claim":"Extending localization to a discrete circuit structure, Kv3.2 was shown to concentrate in cerebellar basket cell axons of the pinceau, implicating it in shaping the Purkinje axon-initial-segment microenvironment.","evidence":"Immunohistochemistry, electron microscopy, and electron tomography","pmids":["15488478"],"confidence":"Medium","gaps":["No direct functional manipulation","Physiological role at the pinceau inferred from localization only"]},{"year":2005,"claim":"Providing a pharmacological handle and testing tissue specificity, ShK was shown to potently block homomeric Kv3.2b and alter interneuron action-potential properties, while having no effect on pancreatic beta-cell current despite Kv3.2 presence.","evidence":"86Rb+ efflux, oocyte and patch-clamp electrophysiology, and native cortical interneuron recordings","pmids":["15709110"],"confidence":"High","gaps":["ShK is not Kv3.2-selective among Kv3 family","Reason for lack of beta-cell functional contribution not established"]},{"year":2008,"claim":"Asking how Kv3.2 levels are set during development, activity deprivation and MAPK/MEK2 inhibition were shown to reduce Kv3.2 mRNA and protein, linking sensory activity to channel expression.","evidence":"Organotypic cortical cultures with TTX, glutamate receptor blockers, MAPK inhibition, RT-PCR, and Western blot","pmids":["18775767"],"confidence":"Medium","gaps":["Mechanism connecting MEK2 to Kv3.2 translation not defined","In vivo relevance of activity-dependent regulation not confirmed"]},{"year":2016,"claim":"Connecting Kv3.2 dysfunction to human epilepsy, a de novo p.D167Y variant was shown to combine loss-of-function on current amplitude with gain-of-function on activation, foreshadowing the dual biophysical nature of disease variants.","evidence":"Heterologous electrophysiology of the variant channel","pmids":["32392612"],"confidence":"Medium","gaps":["Single variant, single method","Net effect on interneuron firing not modeled"]},{"year":2022,"claim":"Systematizing genotype-to-mechanism, multiple DEE variants were shown to produce gain-of-function (shifted voltage dependence, altered kinetics) while a milder GGE variant produced loss-of-function, correlating biophysical class with clinical severity.","evidence":"Xenopus oocyte electrophysiology of multiple variants with exome sequencing","pmids":["35314505","36087422"],"confidence":"Medium","gaps":["GOF/LOF dichotomy complicated by variants with mixed effects","Native interneuron behavior inferred mainly from computational models"]},{"year":2022,"claim":"Defining the structural basis of variant effects, proximal pore-region variants were shown to act through distinct mechanisms — p.V469L sterically blocking permeation versus p.V471L stabilizing the open state — confirmed by molecular dynamics.","evidence":"Whole-exome sequencing, computational structural modeling, patch-clamp, MD simulation, and 4-AP pharmacology","pmids":["36035247"],"confidence":"High","gaps":["Models built on homology/cryo-EM of related channel rather than Kv3.2 itself","Differential 4-AP response not translated to clinical use"]},{"year":2024,"claim":"Resolving an atomic-level gain-of-function mechanism, the p.Cys125Tyr variant was shown to stabilize the open conformation through a π-π stacking interaction in the T1 domain, with network modeling demonstrating impaired interneuron excitability and cortical disinhibition.","evidence":"Variant electrophysiology, cryo-EM-guided modeling, MD simulation, and multicompartment PV-interneuron network modeling","pmids":["38194456"],"confidence":"High","gaps":["T1-domain mechanism not validated in native neurons","Generalizability to other T1-domain variants untested"]},{"year":2023,"claim":"Probing phosphorylation in disease, reduced Kv3.2 phosphorylation was shown to drive mediodorsal thalamic hyperactivation in a PTSD model, with siRNA knockdown of protein phosphatase 6 restoring fear extinction.","evidence":"In vivo lipid-nanoparticle siRNA, fear extinction behavior, and machine-learning neuronal encoding analysis","pmids":["38102998"],"confidence":"Medium","gaps":["Direct dephosphorylation of Kv3.2 by PP6 not biochemically demonstrated","Single-lab in vivo model"]},{"year":2025,"claim":"Toward mechanism-matched therapy, norfluoxetine was shown to inhibit the gain-of-function V473A variant with ~7-fold selectivity over wild type, demonstrating that pathogenic channels can be preferentially suppressed.","evidence":"Whole-cell patch-clamp in HEK293 cells with fluoxetine/norfluoxetine dose-response","pmids":["39881864"],"confidence":"Medium","gaps":["In vitro IC50 only; no in vivo efficacy","Selectivity across other GOF variants not tested"]},{"year":null,"claim":"It remains unresolved how Kv3.2 phosphorylation sites, native heteromer stoichiometry, and variant-specific biophysics integrate to determine circuit-level inhibition and which pharmacological strategy is optimal for each variant class in patients.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No mapped Kv3.2 phosphosites linked to PKA/PP6 regulation in vivo","No structure of Kv3.2 itself; mechanisms inferred from Kv3.1 cryo-EM and modeling","No demonstrated in vivo rescue of DEE phenotypes by variant-selective drugs"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,3,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,5]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[16]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1,2]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,8,10]}],"complexes":["Kv3.1/Kv3.2 heteromeric voltage-gated K+ channel"],"partners":["KCNC1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96PR1","full_name":"Voltage-gated potassium channel KCNC2","aliases":["Potassium voltage-gated channel subfamily C member 2","Shaw-like potassium channel","Voltage-gated potassium channel Kv3.2"],"length_aa":638,"mass_kda":70.2,"function":"Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain. Contributes to the regulation of the fast action potential repolarization and in sustained high-frequency firing in neurons of the central nervous system. Homotetramer channels mediate delayed-rectifier voltage-dependent potassium currents that activate rapidly at high-threshold voltages and inactivate slowly. Forms tetrameric channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane (Probable) (PubMed:15709110, PubMed:35314505, PubMed:36090251). Can form functional homotetrameric and heterotetrameric channels that contain variable proportions of KCNC1, and possibly other family members as well; channel properties depend on the type of alpha subunits that are part of the channel. Channel properties may be modulated either by the association with ancillary subunits, such as KCNE1, KCNE2 or KCNE3 or indirectly by nitric oxide (NO) through a cGMP- and PKG-mediated signaling cascade, slowing channel activation and deactivation of delayed rectifier potassium channels (By similarity). Contributes to fire sustained trains of very brief action potentials at high frequency in retinal ganglion cells, thalamocortical and suprachiasmatic nucleus (SCN) neurons and in hippocampal and neocortical interneurons (PubMed:15709110). Sustained maximal action potential firing frequency in inhibitory hippocampal interneurons is negatively modulated by histamine H2 receptor activation in a cAMP- and protein kinase (PKA) phosphorylation-dependent manner. Plays a role in maintaining the fidelity of synaptic transmission in neocortical GABAergic interneurons by generating action potential (AP) repolarization at nerve terminals, thus reducing spike-evoked calcium influx and GABA neurotransmitter release. Required for long-range synchronization of gamma oscillations over distance in the neocortex. Contributes to the modulation of the circadian rhythm of spontaneous action potential firing in suprachiasmatic nucleus (SCN) neurons in a light-dependent manner (By similarity)","subcellular_location":"Cell membrane; Membrane; Perikaryon; Cell projection, axon; Cell projection, dendrite; Postsynaptic cell membrane; Presynaptic cell membrane; Synapse, synaptosome; Synapse; Apical cell membrane; Basolateral cell membrane","url":"https://www.uniprot.org/uniprotkb/Q96PR1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNC2","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNC2","total_profiled":1310},"omim":[{"mim_id":"619913","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103; DEE103","url":"https://www.omim.org/entry/619913"},{"mim_id":"615579","title":"ATAXIN 7-LIKE 3B; ATXN7L3B","url":"https://www.omim.org/entry/615579"},{"mim_id":"600235","title":"SODIUM VOLTAGE-GATED CHANNEL, BETA SUBUNIT 1; SCN1B","url":"https://www.omim.org/entry/600235"},{"mim_id":"308350","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1","url":"https://www.omim.org/entry/308350"},{"mim_id":"176256","title":"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 2; KCNC2","url":"https://www.omim.org/entry/176256"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":33.8}],"url":"https://www.proteinatlas.org/search/KCNC2"},"hgnc":{"alias_symbol":["Kv3.2"],"prev_symbol":[]},"alphafold":{"accession":"Q96PR1","domains":[{"cath_id":"3.30.710.10","chopping":"1-39_97-171","consensus_level":"medium","plddt":85.3038,"start":1,"end":171},{"cath_id":"1.10.287.70","chopping":"368-487","consensus_level":"high","plddt":89.7853,"start":368,"end":487},{"cath_id":"1.20.120","chopping":"208-364","consensus_level":"high","plddt":84.5401,"start":208,"end":364}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96PR1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96PR1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96PR1-F1-predicted_aligned_error_v6.png","plddt_mean":67.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNC2","jax_strain_url":"https://www.jax.org/strain/search?query=KCNC2"},"sequence":{"accession":"Q96PR1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96PR1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96PR1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96PR1"}},"corpus_meta":[{"pmid":"11124984","id":"PMC_11124984","title":"Impaired fast-spiking, suppressed cortical inhibition, and increased susceptibility to seizures in mice lacking Kv3.2 K+ channel proteins.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11124984","citation_count":144,"is_preprint":false},{"pmid":"10903572","id":"PMC_10903572","title":"H2 histamine receptor-phosphorylation of Kv3.2 modulates interneuron fast spiking.","date":"2000","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10903572","citation_count":87,"is_preprint":false},{"pmid":"10482766","id":"PMC_10482766","title":"Kv3.1-Kv3.2 channels underlie a high-voltage-activating component of the delayed rectifier K+ current in projecting neurons from the globus pallidus.","date":"1999","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/10482766","citation_count":83,"is_preprint":false},{"pmid":"12000114","id":"PMC_12000114","title":"Developmental expression of potassium-channel subunit Kv3.2 within subpopulations of mouse hippocampal inhibitory interneurons.","date":"2002","source":"Hippocampus","url":"https://pubmed.ncbi.nlm.nih.gov/12000114","citation_count":58,"is_preprint":false},{"pmid":"15709110","id":"PMC_15709110","title":"Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channels.","date":"2005","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15709110","citation_count":38,"is_preprint":false},{"pmid":"16413129","id":"PMC_16413129","title":"Differential expression of Kv3.1b and Kv3.2 potassium channel subunits in interneurons of the basolateral amygdala.","date":"2006","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16413129","citation_count":33,"is_preprint":false},{"pmid":"15488478","id":"PMC_15488478","title":"Potassium channel subunit Kv3.2 and the water channel aquaporin-4 are selectively localized to cerebellar pinceau.","date":"2004","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15488478","citation_count":33,"is_preprint":false},{"pmid":"19634181","id":"PMC_19634181","title":"Quantitative analysis of neurons with Kv3 potassium channel subunits, Kv3.1b and Kv3.2, in macaque primary visual cortex.","date":"2009","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19634181","citation_count":27,"is_preprint":false},{"pmid":"31972370","id":"PMC_31972370","title":"A de novo heterozygous mutation in KCNC2 gene implicated in severe developmental and epileptic encephalopathy.","date":"2020","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31972370","citation_count":22,"is_preprint":false},{"pmid":"34448338","id":"PMC_34448338","title":"A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy.","date":"2021","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/34448338","citation_count":21,"is_preprint":false},{"pmid":"35314505","id":"PMC_35314505","title":"Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants.","date":"2022","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35314505","citation_count":20,"is_preprint":false},{"pmid":"23475819","id":"PMC_23475819","title":"Deletion of chromosome 12q21 affecting KCNC2 and ATXN7L3B in a family with neurodevelopmental delay and ataxia.","date":"2013","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23475819","citation_count":18,"is_preprint":false},{"pmid":"16460880","id":"PMC_16460880","title":"Developmental changes in the expression of calbindin and potassium-channel subunits Kv3.1b and Kv3.2 in mouse Renshaw cells.","date":"2006","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16460880","citation_count":17,"is_preprint":false},{"pmid":"38102998","id":"PMC_38102998","title":"Restoring the Function of Thalamocortical Circuit Through Correcting Thalamic Kv3.2 Channelopathy Normalizes Fear Extinction Impairments in a PTSD Mouse Model.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38102998","citation_count":16,"is_preprint":false},{"pmid":"18775767","id":"PMC_18775767","title":"Neuronal activity and TrkB ligands influence Kv3.1b and Kv3.2 expression in developing cortical interneurons.","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18775767","citation_count":16,"is_preprint":false},{"pmid":"32392612","id":"PMC_32392612","title":"Whole-Exome Sequencing in NF1-Related West Syndrome Leads to the Identification of KCNC2 as a Novel Candidate Gene for Epilepsy.","date":"2020","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32392612","citation_count":16,"is_preprint":false},{"pmid":"38194456","id":"PMC_38194456","title":"A structurally precise mechanism links an epilepsy-associated KCNC2 potassium channel mutation to interneuron dysfunction.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38194456","citation_count":15,"is_preprint":false},{"pmid":"27623749","id":"PMC_27623749","title":"An integrative study identifies KCNC2 as a novel predisposing factor for childhood obesity and the risk of diabetes in the Korean population.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27623749","citation_count":15,"is_preprint":false},{"pmid":"21234782","id":"PMC_21234782","title":"Selective underexpression of Kv3.2 and Kv3.4 channels in the cortex of rats exposed to ethanol during early postnatal life.","date":"2011","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/21234782","citation_count":14,"is_preprint":false},{"pmid":"35366058","id":"PMC_35366058","title":"Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy characterized by long-read sequencing.","date":"2022","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/35366058","citation_count":13,"is_preprint":false},{"pmid":"18708127","id":"PMC_18708127","title":"Visual experience regulates Kv3.1b and Kv3.2 expression in developing rat visual cortex.","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18708127","citation_count":11,"is_preprint":false},{"pmid":"36035247","id":"PMC_36035247","title":"Personalized structural biology reveals the molecular mechanisms underlying heterogeneous epileptic phenotypes caused by de novo KCNC2 variants.","date":"2022","source":"HGG advances","url":"https://pubmed.ncbi.nlm.nih.gov/36035247","citation_count":11,"is_preprint":false},{"pmid":"36087422","id":"PMC_36087422","title":"Investigation of novel de novo KCNC2 variants causing severe developmental and early-onset epileptic encephalopathy.","date":"2022","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/36087422","citation_count":8,"is_preprint":false},{"pmid":"36090251","id":"PMC_36090251","title":"Emerging evidence of genotype-phenotype associations of developmental and epileptic encephalopathy due to KCNC2 mutation: Identification of novel R405G.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36090251","citation_count":5,"is_preprint":false},{"pmid":"37203270","id":"PMC_37203270","title":"Novel KCNC2 variant associated with developmental and epileptic encephalopathy.","date":"2023","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37203270","citation_count":2,"is_preprint":false},{"pmid":"37360341","id":"PMC_37360341","title":"KCNC2 variants of uncertain significance are also associated to various forms of epilepsy.","date":"2023","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37360341","citation_count":2,"is_preprint":false},{"pmid":"39881864","id":"PMC_39881864","title":"Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy.","date":"2025","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39881864","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":15285,"output_tokens":4325,"usd":0.055365,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12313,"output_tokens":4306,"usd":0.084608,"stage2_stop_reason":"end_turn"},"total_usd":0.139973,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"Kv3.2 knockout mice showed impaired high-frequency firing specifically in fast-spiking (FS) GABAergic interneurons of deep cortical layers (5-6) where Kv3.2 is normally prominently expressed, but not in superficial layer FS neurons where Kv3.2 is weakly expressed. This establishes Kv3.2 as necessary for high-frequency firing in these interneurons.\",\n      \"method\": \"Whole-cell electrophysiological recording in Kv3.2 knockout mice; immunocytochemical identification of FS interneurons\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with layer-specific electrophysiological phenotype, multiple orthogonal methods, replicated across conditions\",\n      \"pmids\": [\"11124984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Kv3.2 knockout mice showed altered cortical EEG patterns and increased susceptibility to epileptic seizures, consistent with suppression of inhibitory interneuron activity rather than hyperexcitability of interneurons, demonstrating Kv3.2 is required for normal cortical inhibitory function.\",\n      \"method\": \"EEG recording and seizure susceptibility testing in Kv3.2 knockout mice\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined EEG and behavioral phenotype, multiple readouts in same study\",\n      \"pmids\": [\"11124984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"H2 histamine receptor activation negatively modulates outward currents through Kv3.2-containing potassium channels via PKA phosphorylation in hippocampal inhibitory interneurons, lowering maximal firing frequency and suppressing high-frequency population oscillations. All these effects were absent in Kv3.2 knockout mice.\",\n      \"method\": \"Electrophysiology in interneurons; PKA pharmacology; Kv3.2 knockout mouse comparison; population oscillation recordings\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout rescue experiment confirming specificity, multiple orthogonal methods (pharmacology, electrophysiology, knockout validation)\",\n      \"pmids\": [\"10903572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Kv3.1 and Kv3.2 proteins form heteromeric channels in parvalbumin-containing pallidal neurons, as demonstrated by co-immunoprecipitation of both subunits from pallidal membrane extracts. These channels underlie the high-voltage-activating, fast-deactivating delayed rectifier K+ current in these neurons.\",\n      \"method\": \"Co-immunoprecipitation from pallidal membrane extracts; electrophysiological recording of freshly dissociated pallidal neurons; heterologous expression comparison\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP combined with electrophysiological characterization of native vs heterologous channels, multiple orthogonal methods\",\n      \"pmids\": [\"10482766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Kv3.2 and Kv3.1b are co-expressed within the same protein complexes in the hippocampus, as shown by immunoprecipitation. Kv3.2 protein is clustered on somata and proximal dendrites of parvalbumin-positive (100%), nitric oxide synthase-positive (86%), and somatostatin-positive (~50%) hippocampal interneurons, but absent from calbindin- and calretinin-containing interneurons.\",\n      \"method\": \"Immunoprecipitation from hippocampal tissue; immunohistochemistry; double immunofluorescence\",\n      \"journal\": \"Hippocampus\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and immunolocalization from single lab with multiple cell-type markers\",\n      \"pmids\": [\"12000114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Kv3.2 is selectively localized to basket cell axons within the cerebellar pinceau (the structure formed by basket cell axons converging on Purkinje cell initial axonal segments), suggesting a role in regulating the microenvironment of the Purkinje cell axon initial segment.\",\n      \"method\": \"Immunohistochemistry, electron microscopy, and electron tomography\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ultrastructural localization by electron tomography, single lab, no direct functional manipulation\",\n      \"pmids\": [\"15488478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ShK (Stichodactyla helianthus peptide) potently inhibits homomeric Kv3.2b channels (IC50 ~0.3–6 nM depending on assay). In mouse cortical GABAergic fast-spiking interneurons, ShK application increased action potential half-width, decreased after-hyperpolarization amplitude, and decreased maximal firing frequency, consistent with Kv3 channel blockade. However, despite Kv3.2 protein presence in human pancreatic beta cells, ShK had no effect on their Kv current, indicating homotetrameric Kv3.2 channels do not contribute significantly to beta cell delayed rectifier current.\",\n      \"method\": \"86Rb+ efflux assay; electrophysiology in Xenopus oocytes and planar patch-clamp; whole-cell patch-clamp in cortical interneurons\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple quantitative in vitro assays across expression systems, native cell validation, single lab\",\n      \"pmids\": [\"15709110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A de novo KCNC2 variant (p.D167Y) identified in a patient with drug-resistant epilepsy demonstrated both a strong loss-of-function effect on current amplitude and a gain-of-function effect on channel activation, indicating a complex functional consequence of this variant.\",\n      \"method\": \"Electrophysiological studies of variant channel expressed in heterologous system\",\n      \"journal\": \"Neuropediatrics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro electrophysiology of variant channel, single lab, single method\",\n      \"pmids\": [\"32392612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Functional electrophysiological analysis of KCNC2 disease variants in Xenopus laevis oocytes demonstrated gain-of-function in 3 severely affected DEE cases (altered voltage dependence, kinetics) and loss-of-function in 1 milder GGE case, linking specific biophysical mechanisms to clinical severity.\",\n      \"method\": \"Electrophysiology in Xenopus laevis oocytes; exome sequencing\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro electrophysiology of multiple variants in expression system, multiple variants tested, single lab\",\n      \"pmids\": [\"35314505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Computational structural modeling and electrophysiological analyses of two proximal KCNC2 variants (p.V469L and p.V471L) revealed heterogeneous mechanisms: p.V469L sterically blocks the channel pore (loss-of-function), while p.V471L stabilizes the open conformation (gain-of-function). Molecular dynamics simulations confirmed that p.V469L increases the energetic barrier for K+ permeation, while p.V471L stabilizes the open state. Both showed differential responses to 4-aminopyridine.\",\n      \"method\": \"Whole-exome sequencing; computational structural modeling; electrophysiology (patch-clamp); molecular dynamics simulations; 4-AP pharmacology\",\n      \"journal\": \"HGG advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods (structural modeling, electrophysiology, MD simulations, pharmacology) on two variants in single study\",\n      \"pmids\": [\"36035247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The epilepsy-associated Kv3.2-p.Cys125Tyr variant causes gain-of-function via a hyperpolarizing shift in voltage dependence of activation, accelerated activation, and delayed deactivation. Cryo-EM structure of Kv3.1 combined with molecular dynamics simulations revealed that Tyr125 forms a π-π stacking interaction with Tyr156 in the α-6 helix of the T1 domain, stabilizing the open conformation. A computational parvalbumin-positive interneuron model demonstrated that this variant impairs neuronal excitability and dysregulates cortical inhibition.\",\n      \"method\": \"Electrophysiology of variant channel; cryo-EM structure leveraging; molecular dynamics simulations; multicompartment computational neuron modeling\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structure-guided mechanism with MD simulation, electrophysiological validation, and computational network modeling; multiple orthogonal methods\",\n      \"pmids\": [\"38194456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Two novel de novo KCNC2 variants (p.Pro470Ser and p.Phe388Leu) in DEE patients demonstrated decreased channel activation and deactivation kinetics in whole-cell patch-clamp recordings from HEK293 cells. p.Phe388Leu and p.Val471Leu variants also showed increased channel conductance and ~20 mV negative shift in voltage-dependent activation threshold. Computational model simulations showed all variants decreased interneuron firing frequency, producing net loss-of-function with disinhibition of neural networks.\",\n      \"method\": \"Whole-cell patch-clamp in HEK293 cells; computational GABAergic interneuron modeling\",\n      \"journal\": \"Seizure\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro patch-clamp combined with computational modeling, single lab, multiple variants tested\",\n      \"pmids\": [\"36087422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Electrophysiological studies of KCNC2 variants of uncertain significance in Xenopus laevis oocytes showed changes in current amplitude and activation/deactivation kinetics depending on the variant. Valproic acid showed no direct effect on Kv3.2 channel behavior in oocytes, suggesting its therapeutic benefit in KCNC2 variant patients occurs through other mechanisms.\",\n      \"method\": \"Electrophysiology in Xenopus laevis oocytes; valproic acid pharmacology\",\n      \"journal\": \"Frontiers in neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro electrophysiology of multiple variants including negative result for VPA, single lab\",\n      \"pmids\": [\"37360341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The Kv3.2-V473A variant (GOF) activates at more hyperpolarized potentials than wild-type Kv3.2 in HEK293 cells. Fluoxetine inhibits both Kv3.2 WT and Kv3.2-V473A variant channels with IC50 ~12 µM. Norfluoxetine (fluoxetine metabolite) inhibits Kv3.2 variant currents with 7-fold greater selectivity (IC50 ~0.4 µM for variant vs ~2.9 µM for WT), selectively suppressing dominant pathogenic channel activity.\",\n      \"method\": \"Whole-cell patch-clamp in HEK293 cells; pharmacological dose-response for fluoxetine and norfluoxetine\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro electrophysiology with quantitative IC50 measurements for pharmacological inhibition, single lab, single method\",\n      \"pmids\": [\"39881864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Decreased phosphorylation of the Kv3.2 channel contributed to hyperactivation of the mediodorsal thalamic nucleus (MD) in a PTSD mouse model, and correction of this channelopathy via siRNA-targeting of protein phosphatase 6 catalytic subunit (using lipid nanoparticle-based RNA therapy) restored fear memory extinction.\",\n      \"method\": \"Functional screening; RNA therapy (lipid nanoparticle-based siRNA); fear extinction behavioral assay; machine learning analysis of neuronal encoding\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo siRNA rescue with behavioral readout and mechanistic link to phosphorylation state, single lab, multiple methods\",\n      \"pmids\": [\"38102998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Kv3.2 mRNA and protein expression in developing rat visual cortex is regulated by neuronal activity: chronic activity deprivation from early postnatal stages prevented postnatal increase in Kv3.2 mRNA; TTX-mediated deprivation reduced Kv3.2 protein. MEK2 signaling appears required for Kv3.2 translation (inhibiting MAPK signaling decreased Kv3.2 protein levels). BDNF and NT4 did not significantly change Kv3.2 protein levels.\",\n      \"method\": \"Organotypic cultures; RT-PCR; Western blot; TTX/glutamate receptor blocker pharmacology; MAPK inhibition\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — multiple pharmacological manipulations in organotypic cultures with mRNA and protein readouts, single lab\",\n      \"pmids\": [\"18775767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"KCNC2 shRNA knockdown in cellular and mouse models induced endoplasmic reticulum (ER) stress and increased hepatic gluconeogenesis, while KCNC2 overproduction decreased ER stress, demonstrating a role in hepatic metabolic regulation.\",\n      \"method\": \"shRNA knockdown; overexpression in cellular and mouse models; ER stress markers; gluconeogenesis assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single shRNA approach, non-neuronal context inconsistent with primary function described in most corpus papers\",\n      \"pmids\": [\"27623749\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Kv3.2 (KCNC2) is a voltage-gated K+ channel subunit that activates at very depolarized potentials (positive to -10 mV) and deactivates rapidly; it forms homotetrameric and heteromeric channels (notably with Kv3.1) clustered on somata and proximal dendrites of parvalbumin-positive fast-spiking GABAergic interneurons, where it is required for sustained high-frequency firing, cortical inhibitory tone, and network oscillations. Its activity is regulated by PKA phosphorylation downstream of H2 histamine receptor signaling, and disease-associated de novo variants cause either gain-of-function (via stabilization of the open conformation, as structurally explained by π-π stacking or open-state stabilization) or loss-of-function (via pore block or kinetic slowing), both of which impair interneuron excitability and produce developmental and epileptic encephalopathy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"KCNC2 encodes Kv3.2, a high-voltage-activating, fast-deactivating voltage-gated K+ channel subunit that endows fast-spiking GABAergic interneurons with the capacity for sustained high-frequency firing and thereby sets cortical inhibitory tone [#0, #1]. The channel assembles as homotetramers and as heteromers with Kv3.1, forming the delayed-rectifier current of parvalbumin-positive interneurons in cortex, hippocampus, pallidum, and cerebellar basket cells, where Kv3.2 protein clusters on somata, proximal dendrites, and specialized axonal structures such as the cerebellar pinceau [#3, #4, #5]. Loss of Kv3.2 selectively impairs deep-layer interneuron high-frequency firing and produces abnormal EEG activity and seizure susceptibility, establishing that interneuron repolarization by Kv3.2 is required for normal network inhibition [#0, #1]. Channel output is dynamically tuned by phosphorylation: H2 histamine-receptor signaling acting through PKA suppresses Kv3.2 current and lowers maximal firing frequency, and reduced channel phosphorylation drives pathological thalamic hyperactivation in a PTSD model [#2, #14]. De novo KCNC2 variants cause developmental and epileptic encephalopathy through two opposing biophysical routes — gain-of-function via hyperpolarizing shifts in activation, accelerated activation, and delayed deactivation (structurally explained by open-state-stabilizing interactions including π-π stacking in the T1 domain), and loss-of-function via pore block or kinetic slowing — both of which impair interneuron excitability and dysregulate cortical inhibition [#8, #9, #10, #11]. Variant-selective pharmacology, including norfluoxetine's preferential inhibition of gain-of-function channels, points toward mechanism-matched therapeutic strategies [#13].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing whether Kv3.2 is functionally required in vivo, genetic deletion pinpointed it as necessary for high-frequency firing in deep-layer fast-spiking interneurons and for normal cortical inhibition, with its loss causing abnormal EEG and seizure susceptibility.\",\n      \"evidence\": \"Whole-cell electrophysiology, EEG, and seizure testing in Kv3.2 knockout mice with immunocytochemical interneuron identification\",\n      \"pmids\": [\"11124984\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve subunit stoichiometry of native channels\", \"Layer- and cell-type specificity of phenotype incompletely mapped beyond deep-layer FS neurons\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Addressing how the native delayed-rectifier current is built, co-immunoprecipitation showed Kv3.2 forms heteromeric channels with Kv3.1 in parvalbumin-positive neurons, explaining the high-voltage-activating, fast-deactivating current.\",\n      \"evidence\": \"Reciprocal co-IP from pallidal membranes plus electrophysiology of native and heterologous channels\",\n      \"pmids\": [\"10482766\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Heteromer stoichiometry not determined\", \"Functional contribution of homomers vs heteromers in vivo not separated\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"To define how channel output is regulated, H2 histamine receptor signaling was shown to suppress Kv3.2 current via PKA phosphorylation, lowering interneuron firing and high-frequency oscillations, with effects absent in knockouts.\",\n      \"evidence\": \"Interneuron electrophysiology, PKA pharmacology, population oscillation recordings, and knockout controls\",\n      \"pmids\": [\"10903572\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation sites on Kv3.2 not mapped\", \"Direct vs indirect PKA action on the channel not distinguished\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Refining cell-type localization, Kv3.2 was found clustered on somata and proximal dendrites of defined hippocampal interneuron subsets and co-complexed with Kv3.1b, sharpening which inhibitory cells depend on this channel.\",\n      \"evidence\": \"Immunoprecipitation and double immunofluorescence in hippocampal tissue\",\n      \"pmids\": [\"12000114\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab immunolocalization\", \"Functional consequence of differential subcellular clustering not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Extending localization to a discrete circuit structure, Kv3.2 was shown to concentrate in cerebellar basket cell axons of the pinceau, implicating it in shaping the Purkinje axon-initial-segment microenvironment.\",\n      \"evidence\": \"Immunohistochemistry, electron microscopy, and electron tomography\",\n      \"pmids\": [\"15488478\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct functional manipulation\", \"Physiological role at the pinceau inferred from localization only\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Providing a pharmacological handle and testing tissue specificity, ShK was shown to potently block homomeric Kv3.2b and alter interneuron action-potential properties, while having no effect on pancreatic beta-cell current despite Kv3.2 presence.\",\n      \"evidence\": \"86Rb+ efflux, oocyte and patch-clamp electrophysiology, and native cortical interneuron recordings\",\n      \"pmids\": [\"15709110\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ShK is not Kv3.2-selective among Kv3 family\", \"Reason for lack of beta-cell functional contribution not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Asking how Kv3.2 levels are set during development, activity deprivation and MAPK/MEK2 inhibition were shown to reduce Kv3.2 mRNA and protein, linking sensory activity to channel expression.\",\n      \"evidence\": \"Organotypic cortical cultures with TTX, glutamate receptor blockers, MAPK inhibition, RT-PCR, and Western blot\",\n      \"pmids\": [\"18775767\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting MEK2 to Kv3.2 translation not defined\", \"In vivo relevance of activity-dependent regulation not confirmed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connecting Kv3.2 dysfunction to human epilepsy, a de novo p.D167Y variant was shown to combine loss-of-function on current amplitude with gain-of-function on activation, foreshadowing the dual biophysical nature of disease variants.\",\n      \"evidence\": \"Heterologous electrophysiology of the variant channel\",\n      \"pmids\": [\"32392612\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single variant, single method\", \"Net effect on interneuron firing not modeled\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Systematizing genotype-to-mechanism, multiple DEE variants were shown to produce gain-of-function (shifted voltage dependence, altered kinetics) while a milder GGE variant produced loss-of-function, correlating biophysical class with clinical severity.\",\n      \"evidence\": \"Xenopus oocyte electrophysiology of multiple variants with exome sequencing\",\n      \"pmids\": [\"35314505\", \"36087422\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GOF/LOF dichotomy complicated by variants with mixed effects\", \"Native interneuron behavior inferred mainly from computational models\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defining the structural basis of variant effects, proximal pore-region variants were shown to act through distinct mechanisms — p.V469L sterically blocking permeation versus p.V471L stabilizing the open state — confirmed by molecular dynamics.\",\n      \"evidence\": \"Whole-exome sequencing, computational structural modeling, patch-clamp, MD simulation, and 4-AP pharmacology\",\n      \"pmids\": [\"36035247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Models built on homology/cryo-EM of related channel rather than Kv3.2 itself\", \"Differential 4-AP response not translated to clinical use\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolving an atomic-level gain-of-function mechanism, the p.Cys125Tyr variant was shown to stabilize the open conformation through a π-π stacking interaction in the T1 domain, with network modeling demonstrating impaired interneuron excitability and cortical disinhibition.\",\n      \"evidence\": \"Variant electrophysiology, cryo-EM-guided modeling, MD simulation, and multicompartment PV-interneuron network modeling\",\n      \"pmids\": [\"38194456\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"T1-domain mechanism not validated in native neurons\", \"Generalizability to other T1-domain variants untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Probing phosphorylation in disease, reduced Kv3.2 phosphorylation was shown to drive mediodorsal thalamic hyperactivation in a PTSD model, with siRNA knockdown of protein phosphatase 6 restoring fear extinction.\",\n      \"evidence\": \"In vivo lipid-nanoparticle siRNA, fear extinction behavior, and machine-learning neuronal encoding analysis\",\n      \"pmids\": [\"38102998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct dephosphorylation of Kv3.2 by PP6 not biochemically demonstrated\", \"Single-lab in vivo model\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Toward mechanism-matched therapy, norfluoxetine was shown to inhibit the gain-of-function V473A variant with ~7-fold selectivity over wild type, demonstrating that pathogenic channels can be preferentially suppressed.\",\n      \"evidence\": \"Whole-cell patch-clamp in HEK293 cells with fluoxetine/norfluoxetine dose-response\",\n      \"pmids\": [\"39881864\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro IC50 only; no in vivo efficacy\", \"Selectivity across other GOF variants not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how Kv3.2 phosphorylation sites, native heteromer stoichiometry, and variant-specific biophysics integrate to determine circuit-level inhibition and which pharmacological strategy is optimal for each variant class in patients.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No mapped Kv3.2 phosphosites linked to PKA/PP6 regulation in vivo\", \"No structure of Kv3.2 itself; mechanisms inferred from Kv3.1 cryo-EM and modeling\", \"No demonstrated in vivo rescue of DEE phenotypes by variant-selective drugs\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 3, 6]},\n      {\"term_id\": \"GO:0005216\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 8, 10]}\n    ],\n    \"complexes\": [\n      \"Kv3.1/Kv3.2 heteromeric voltage-gated K+ channel\"\n    ],\n    \"partners\": [\n      \"KCNC1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}